Atara Biotherapeutics Stock Technical Analysis

ATRA Stock  USD 0.71  0.01  0.74%   
As of the 25th of April, Atara Biotherapeutics shows the mean deviation of 5.2, and Risk Adjusted Performance of 0.0455. Atara Biotherapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Atara Biotherapeutics, which can be compared to its peers. Please confirm Atara Biotherapeutics jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Atara Biotherapeutics is priced correctly, providing market reflects its regular price of 0.7147 per share. As Atara Biotherapeutics is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Atara Biotherapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Atara, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Atara
  
Atara Biotherapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Atara Biotherapeutics Analyst Consensus

Target PriceAdvice# of Analysts
14.72Buy7Odds
Atara Biotherapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Atara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Atara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Atara Biotherapeutics, talking to its executives and customers, or listening to Atara conference calls.
Atara Analyst Advice Details
Atara Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Atara Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Atara Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Atara Biotherapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Atara Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Atara Biotherapeutics Trend Analysis

Use this graph to draw trend lines for Atara Biotherapeutics. You can use it to identify possible trend reversals for Atara Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Atara Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Atara Biotherapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Atara Biotherapeutics applied against its price change over selected period. The best fit line has a slop of   0.0029  , which may suggest that Atara Biotherapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.31, which is the sum of squared deviations for the predicted Atara Biotherapeutics price change compared to its average price change.

About Atara Biotherapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Atara Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Atara Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Atara Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Atara Biotherapeutics. By analyzing Atara Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Atara Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Atara Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 (projected)
Dividend Yield0.0018620.0021420.003211
Price To Sales Ratio5.266.346.02

Atara Biotherapeutics April 25, 2024 Technical Indicators

Most technical analysis of Atara help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Atara from various momentum indicators to cycle indicators. When you analyze Atara charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Atara Biotherapeutics April 25, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Atara stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Atara Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Atara Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atara Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atara Biotherapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atara Biotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Atara Stock analysis

When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Atara Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.61)
Revenue Per Share
0.081
Quarterly Revenue Growth
13.457
Return On Assets
(0.62)
Return On Equity
(20.15)
The market value of Atara Biotherapeutics is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherapeutics' market value can be influenced by many factors that don't directly affect Atara Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atara Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.